Zepbound vs Wegovy comes down to this: if your only goal is the biggest weight loss, Zepbound has the edge. In the one head-to-head trial, people on Zepbound lost an average of 20.2% of their body weight, compared with 13.7% on Wegovy, over 72 weeks.
But “biggest” isn’t always “best for you.” Wegovy has approvals Zepbound doesn’t, like heart-risk reduction, liver disease, and teens 12 and older. Costs are closer than they look, and side effects overlap. So instead of a single verdict, this guide runs the Zepbound vs Wegovy comparison as a six-round match, then helps you pick.
Medical note: This Zepbound vs Wegovy guide is educational, not medical advice. Both are prescription drugs and neither is right for everyone. Talk to your doctor before you start, switch or stop. See our Health Disclaimer -> https://fit4rever.com/health-disclaimer/].
The 30-Second Decision Guide
Skip to your situation. The rest of this Zepbound vs Wegovy guide explains why.
| If this sounds like you… | Lean toward | Why |
|---|---|---|
| I want the maximum weight loss | Zepbound | Higher average loss in the head-to-head trial |
| I have heart disease and obesity | Wegovy | Approved to lower heart attack and stroke risk |
| I have moderate-to-severe sleep apnea | Zepbound | Only one labeled for it |
| I have MASH (fatty liver with scarring) | Wegovy injection | Has the MASH indication |
| I’m 12 to 17 | Wegovy injection | Zepbound is for adults only |
| I hate needles | Wegovy pill | Only weight loss pill of the two |
| My insurance covers only one | Whichever it covers | Coverage often decides |
Not on the list? Keep reading, because the right Zepbound vs Wegovy answer often depends on details a quick table can’t capture.
Meet the Contenders
Zepbound contains tirzepatide, made by Eli Lilly. It activates two gut-hormone receptors, GIP and GLP-1. It’s a weekly injection in doses from 2.5 mg to 15 mg.
Wegovy contains semaglutide, made by Novo Nordisk. It activates GLP-1 only. It comes as a weekly injection (0.25 mg up to 2.4 mg, plus a 7.2 mg “HD” dose approved in March 2026) and as a daily pill.
That second pathway is the main reason Zepbound tends to produce bigger average results in the Zepbound vs Wegovy matchup. Now let’s see how the two did, round by round.
Round 1: Which Is Better Zepbound or Wegovy for Weight Loss?
Winner: Zepbound. In the Zepbound vs Wegovy weight loss round, the gap is clear and consistent.
The best evidence in the Zepbound vs Wegovy debate is SURMOUNT-5. It enrolled 751 adults with obesity or overweight plus at least one weight-related condition. After 72 weeks:
| Result | Zepbound | Wegovy |
|---|---|---|
| Average weight loss | 20.2% | 13.7% |
| Average pounds lost | about 50.3 lb (22.8 kg) | about 33.1 lb (15.0 kg) |
| Lost 10% or more | 81.6% | 60.5% |
| Lost 15% or more | 64.6% | 40.1% |
| Lost 20% or more | 48.4% | 27.3% |
| Lost 25% or more | 31.6% | 16.1% |
| Waist shrink | 18.4 cm (7.2 in) | 13.0 cm (5.1 in) |
Picture 100 people on each drug. Roughly 32 on Zepbound reached a quarter of their body weight lost, versus about 16 on Wegovy.
Two fair warnings:
- Eli Lilly funded SURMOUNT-5, and it was open-label (everyone knew which drug they got).
- Wegovy HD (7.2 mg) averaged 20.7% in a separate trial called STEP UP. That’s close to Zepbound’s result, but the two weren’t compared directly, so don’t read it as a tie.
Round 2: Zepbound vs Wegovy Side Effects
Winner: depends on what bothers you.
Zepbound vs Wegovy side effects are mostly digestive, and both drugs cause them, usually while the dose is going up: nausea, diarrhea, constipation, vomiting, reflux, bloating, and tiredness.
The product labels list these rates at top doses. They come from different trials with different people, so use them as a rough guide, not a scoreboard.
| Side effect | Zepbound 15 mg | Wegovy 2.4 mg |
|---|---|---|
| Nausea | about 28 to 31% | about 44% |
| Diarrhea | about 23% | about 30% |
| Vomiting | about 13% | about 24% |
| Constipation | about 11% | about 24% |
The head-to-head trial gives a fairer comparison:
- Quit because of stomach problems: 2.7% on Zepbound vs 5.6% on Wegovy.
- Serious adverse events: 4.8% vs 3.5%. Small numbers, no clear gap.
- Injection-site reactions: more common on Zepbound (32 events vs 1). None caused anyone to stop.
In plain terms: Wegovy tends to bring more nausea and constipation on paper. Zepbound brings a little more skin irritation. Fewer people quit Zepbound over stomach trouble in the trial.
Ways to ease the first weeks (general tips, not medical advice):
- Eat smaller meals and stop when you feel full.
- Go easy on greasy, fried, and very sugary food.
- Sip water all day.
- Add fiber slowly, and tell your prescriber early if side effects are severe. They can slow your dose increases.
Round 3: Which Is Safer Wegovy or Zepbound?
Winner: tie.
No Zepbound vs Wegovy trial was designed to prove one is safer, and the safety profiles are close.
What they share:
- A boxed warning about thyroid C-cell tumors seen in rodents. Don’t use either if you or a close relative has had medullary thyroid carcinoma or MEN 2.
- Risks of gallbladder problems, pancreatitis, dehydration, and kidney strain from vomiting or diarrhea.
- Low blood sugar if combined with insulin or sulfonylureas.
- No use in pregnancy. Tirzepatide can also make oral birth control less reliable, so ask about backup contraception.
Where they differ:
- Track record. Wegovy was approved in June 2021 and Zepbound in 2023, so Wegovy has longer real-world use.
- Heart data. Wegovy has a labeled heart-risk reduction indication for adults with known heart disease.
- Dropouts. Fewer people left Zepbound for stomach reasons in SURMOUNT-5.
The safer drug is the one that fits your health history. Your doctor will weigh your heart, liver, kidneys, gallbladder, medicines, and family history. If you’ve ever had an eating disorder, mention it before starting either drug.
Round 4: Zepbound vs Wegovy Cost
Winner: it depends on your dose and insurance.
These Zepbound vs Wegovy prices are approximate US figures as of October 2026. They change often, so check LillyDirect and NovoCare before you buy.
| Zepbound | Wegovy | |
|---|---|---|
| List price | about $1,086 per month | about $1,349 per month |
| Self-pay | $299 (2.5 mg), $399 (5 mg), $449 (7.5 to 15 mg) via LillyDirect vials | $199 for the first two fills of 0.25 mg and 0.5 mg (offer through Dec 31, 2026), then about $349 |
| High dose | Same $449 tier | Wegovy HD 7.2 mg about $399 |
| Pill | None | From about $149, by dose |
| Commercial insurance | As low as $25 with the Lilly Savings Card | Similar savings programs, if covered |
The Zepbound vs Wegovy cost math most pages skip:
- Zepbound’s $449 maintenance price needs refills within 45 days.
- At maintenance doses, Zepbound costs roughly 29% more per month than Wegovy’s $349 ($449 vs $349), about $1,200 more a year. The trial showed about 47% more relative weight loss. Whether that’s worth it is your call.
- The cheapest way in is often Zepbound’s $299 starter dose or Wegovy’s $199 intro offer, but starter doses don’t last because you move up to higher doses.
- Compounded versions are cheaper but aren’t FDA-approved, and quality varies. Discuss with a licensed prescriber.
Outside the US: prices, brand names, and coverage differ in the UK, Canada, Australia, Germany, and the UAE. Ask a local pharmacy or check your national health service.
Round 5: Extra Approvals and Convenience
Winner: Wegovy (on points), with one big Zepbound exception.
| Zepbound | Wegovy | |
|---|---|---|
| Sleep apnea (moderate-to-severe, with obesity) | Yes | No |
| Heart attack and stroke risk reduction | No | Yes (with heart disease) |
| MASH liver disease | No | Yes (injection, accelerated approval) |
| Ages 12 to 17 | No | Yes (injection) |
| Daily pill option | No | Yes (13.6% average loss at 64 weeks) |
| Higher-dose option | Up to 15 mg | Up to 7.2 mg (HD) |
In the Zepbound vs Wegovy approvals race, sleep apnea is a big deal for Zepbound. If you have heart or liver disease, or you’re a teen, or you want a pill, Wegovy gets the point.
Bonus Round: Zepbound vs Wegovy vs Mounjaro
Mounjaro and Zepbound are the same drug, so Zepbound vs Wegovy also covers Mounjaro vs Wegovy. Both are tirzepatide from Eli Lilly, at the same doses (2.5 mg to 15 mg). The difference is the label.
| Mounjaro | Zepbound | Wegovy | |
|---|---|---|---|
| Active ingredient | Tirzepatide | Tirzepatide | Semaglutide |
| US approval | Type 2 diabetes (2022) | Weight loss (2023), sleep apnea | Weight loss (2021), heart risk, MASH |
| US self-pay | About $499 flat, reported | $299 to $449 | $199 to $349 |
| Outside the US | Also sold for weight management in some markets | Mostly a US brand | Sold in many countries |
What this means for you:
- In the US, Zepbound is the weight loss brand.
- In the UK, Australia, Europe, and the UAE, you’ll often see “Mounjaro vs Wegovy” instead, because Mounjaro is the tirzepatide brand sold there for weight management for certain adults.
- Ozempic is the diabetes version of Wegovy’s semaglutide.
So the Zepbound vs Wegovy vs Mounjaro question really means two molecules: tirzepatide (Zepbound and Mounjaro) and semaglutide (Wegovy and Ozempic).
The Final Scorecard
| Round | Winner |
|---|---|
| 1. Weight loss | Zepbound |
| 2. Side effects | Tie (different trade-offs) |
| 3. Safety | Tie |
| 4. Cost | Depends on dose and insurance |
| 5. Extra approvals | Wegovy (Zepbound wins sleep apnea) |
| Bonus: Mounjaro | Same as Zepbound |
Zepbound wins the headline round of Zepbound vs Wegovy. Wegovy wins on versatility. Neither wins everything.
What the Scorecard Can’t Tell You
Numbers describe averages, and in Zepbound vs Wegovy trials, as in life, you’re not an average.
- Your response may differ. In every trial, some people lost far more than the average, and some lost far less, on both drugs.
- Stopping often means regaining. Studies of both drugs show many people regain a good part of the weight after they stop. Ask your doctor about a long-term plan.
- The head-to-head trial has limits. It was Lilly-funded, open-label, and pushed doses up fast. Real life is often slower.
- Medication isn’t the whole plan. Whichever side of Zepbound vs. Wegovy you pick, protein, strength training, and sleep still matter. People who skip these often lose muscle along with fat, and that makes the result harder to keep.
[ADD YOUR OWN PHOTO/EXPERIENCE HERE: for example, a short quote from a pharmacist, doctor or dietitian about how they help patients choose. Don’t invent one.]
Eating Well on Either Drug: Protein-First Ideas
Whichever you choose in Zepbound vs Wegovy, both drugs shrink your appetite, so what you do eat should earn its place. A commonly suggested protein range is about 1.2 to 1.6 g per kg of body weight (0.54 to 0.73 g per lb), but your doctor or dietitian should set your own target. Our [INTERNAL LINK: macro calculator -> https://fit4rever.com/macro-calculator/] and [INTERNAL LINK: TDEE calculator -> https://fit4rever.com/tdee-calculator/] can give you a starting point.
Values are approximate. Check your labels.
| Food | Portion | Calories | Protein |
|---|---|---|---|
| Plain nonfat Greek yogurt | 170 g (6 oz) | ~100 kcal | ~17 g |
| Low-fat cottage cheese | 113 g (4 oz) | ~85 kcal | ~12 g |
| Hard-boiled eggs | 2 large (~100 g / 3.5 oz) | ~155 kcal | ~12 to 13 g |
| Shelled edamame | 100 g (3.5 oz) | ~120 kcal | ~11 g |
| Tuna pouch (in water) | 85 g (3 oz) | ~70 to 100 kcal | ~17 to 20 g |
| Roasted chickpeas | 30 g (1 oz) | ~120 kcal | ~6 g |
Tips that help with side effects:
- Eat the protein part of the meal first, in small portions.
- Edamame and chickpeas add fiber, which can help with constipation. Add them slowly and drink water.
- Cold foods like yogurt, cottage cheese, and tuna are often easier when you feel queasy.
- Lift weights two or three times a week to protect muscle.
7 Questions to Ask Your Doctor
Take this list to your appointment:
- Given my health history, which side of Zepbound vs Wegovy fits me better?
- Do I have any condition that rules either one out (thyroid cancer history, pancreatitis, gallbladder disease)?
- Which does my insurance cover, and what will I pay each month?
- What dose will I start on, and how fast will we go up?
- What should I do about nausea, constipation, or low appetite?
- Do I need backup contraception, or changes to my other medicines?
- What’s the plan if I want to stop later?
FAQ: Zepbound vs Wegovy
Quick answers to the Zepbound vs Wegovy questions people search most.
Is Zepbound better than Wegovy?
For weight loss alone, yes, based on the head-to-head SURMOUNT-5 trial (20.2% vs 13.7% at 72 weeks). Wegovy may fit better if you have heart disease, MASH, are a teen, or want a pill.
Which is safer, Wegovy or Zepbound?
Neither is proven safer. Both carry the same boxed thyroid warning and similar risks. Wegovy has a longer track record and a heart-risk indication. Fewer people quit Zepbound for stomach problems in SURMOUNT-5.
Which has worse side effects, Zepbound or Wegovy?
They’re similar, mostly nausea, diarrhea, vomiting, and constipation during dose increases. Label rates at top doses are higher for Wegovy, but they come from different trials. Zepbound had more injection-site reactions.
Is Zepbound cheaper than Wegovy?
At list price, yes. On US self-pay programs, they’re close: Zepbound runs about $299 to $449 and Wegovy about $199 to $349. Insurance coverage usually matters most.
Are Mounjaro and Zepbound the same?
Yes. Both are tirzepatide at the same doses. Zepbound is the US weight loss brand, and Mounjaro is the diabetes brand, though Mounjaro is sold for weight management in some other countries.
Bottom Line: Zepbound vs Wegovy
Zepbound wins the Zepbound vs Wegovy match on weight loss: 20.2% to 13.7% in the only head-to-head trial. Wegovy fights back with a heart-risk label, a liver label, approval from age 12, a daily pill, and a higher HD dose that’s narrowing the gap.
In the Zepbound vs Wegovy comparison, side effects and safety are close, and cost often comes down to insurance. So choose based on your health, budget, and goals, and decide with your doctor.
Next step: Get our free high-protein snack list by email. [PRIMARY CTA: Subscribe to the fit4rever.com newsletter -> https://fit4rever.com/newsletter/] Or keep reading: [SECONDARY CTA – INTERNAL LINK: healthy diet plans -> https://fit4rever.com/diets/]
Medical disclaimer: This article is for general information and isn’t medical advice. Prescription weight loss drugs aren’t right for everyone. Talk to a licensed healthcare professional about your own situation before starting, changing or stopping any medication. Prices and approvals change; confirm with the manufacturers and your insurer.
